Osaic Holdings
RAPT

Osaic Holdings’s RAPT Therapeutics RAPT Stock Holding History

Osaic Holdings’s Portfolio RAPT Stock Details RAPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-1
Closed -$6 – 7861
2025
Q1 		$6 Hold
1
– – ﹤0.01% 7389
2024
Q4 		$9 Buy
+1
New +$13 ﹤0.01% 7346
2024
Q3 		– Sell
-11
Closed -$275 – 7526
2024
Q2 		$275 Buy
+11
New +$508 ﹤0.01% 7121
2024
Q1 		– Sell
-99
Closed -$19.6K – 7364
2023
Q4 		$19.6K Buy
99
+73
+281% +$9.04K ﹤0.01% 5508
2023
Q3 		$3.42K Sell
26
-15
-37% -$2.45K ﹤0.01% 6428
2023
Q2 		$6.55K Hold
41
– – ﹤0.01% 6188
2023
Q1 		$5.55K Buy
41
+16
+64% +$3.24K ﹤0.01% 6278
2022
Q4 		$4K Hold
25
– – ﹤0.01% 6420
2022
Q3 		$5K Hold
25
– – ﹤0.01% 6379
2022
Q2 		$4K Hold
25
– – ﹤0.01% 6619
2022
Q1 		$401K Hold
25
– – ﹤0.01% 3430
2021
Q4 		$8K Hold
25
– – ﹤0.01% 6409
2021
Q3 		$6K Buy
+25
New +$6.61K ﹤0.01% 6460
2021
Q2 		– Sell
-125
Closed -$22K – 7106
2021
Q1 		$22K Hold
125
– – ﹤0.01% 5414
2020
Q4 		$20K Buy
125
+106
+558% +$23K ﹤0.01% 5160
2020
Q3 		$5K Hold
19
– – ﹤0.01% 5579
2020
Q2 		$4K Hold
19
– – ﹤0.01% 5582
2020
Q1 		$3K Buy
+19
New +$4.33K ﹤0.01% 5565

Other funds holding RAPT

MVM
Medicxi Ventures Management St. Helier, Jersey $982M AUM 210.17% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
FCMV
Foresite Capital Management VI Larkspur, California $460M AUM 261.77% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
CG
Column Group San Francisco, California $101M AUM 290.34% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return

Osaic Holdings's RAPT Position: Q2 2025 in Review

Osaic Holdings sold out of RAPT Therapeutics (RAPT) in Q2 2025, closing a stake of 1 share — an estimated $6 sold.

Osaic Holdings first reported a position in RAPT in Q1 2020 and held it in 18 quarters. The position peaked at $401K in Q1 2022. 50 funds tracked by Wall St. Rank hold RAPT as of Q2 2025.

  • Osaic Holdings reported no remaining RAPT Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Osaic Holdings sold 1 RAPT Therapeutics share in Q2 2025, an estimated $6.
  • Osaic Holdings first reported a position in RAPT Therapeutics in Q1 2020 and held it in 18 quarters.
  • Osaic Holdings's RAPT Therapeutics position peaked at $401K in Q1 2022.
  • 50 funds tracked by Wall St. Rank held RAPT Therapeutics as of Q2 2025.

Based on Osaic Holdings's 13F filing for Q2 2025, filed 13 Aug 2025.